(Q50882019)

English

In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.

scientific article published on 19 July 2017

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit